Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.

Goetz MP, Sun JX, Suman VJ, Silva GO, Perou CM, Nakamura Y, Cox NJ, Stephens PJ, Miller VA, Ross JS, Chen D, Safgren SL, Kuffel MJ, Ames MM, Kalari KR, Gomez HL, Gonzalez-Angulo AM, Burgues O, Brauch HB, Ingle JN, Ratain MJ, Yelensky R.

J Natl Cancer Inst. 2014 Dec 8;107(2). pii: dju401. doi: 10.1093/jnci/dju401.

2.

Pharmacokinetics of endoxifen and tamoxifen in female mice: implications for comparative in vivo activity studies.

Reid JM, Goetz MP, Buhrow SA, Walden C, Safgren SL, Kuffel MJ, Reinicke KE, Suman V, Haluska P, Hou X, Ames MM.

Cancer Chemother Pharmacol. 2014 Dec;74(6):1271-8. doi: 10.1007/s00280-014-2605-7. Epub 2014 Oct 16.

3.

Methylenedioxy- and ethylenedioxy-fused indolocarbazoles: potent human topoisomerase I inhibitors and antitumor agents.

Zembower DE, Xie Y, Koohang A, Kuffel MJ, Ames MM, Zhou Y, Mishra R, Mar AA, Flavin MT, Xu ZQ.

Anticancer Agents Med Chem. 2012 Nov;12(9):1117-31.

PMID:
22339065
4.

SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen.

Moyer AM, Suman VJ, Weinshilboum RM, Avula R, Black JL, Safgren SL, Kuffel MJ, Ames MM, Ingle JN, Goetz MP.

Pharmacogenomics. 2011 Nov;12(11):1535-43. doi: 10.2217/pgs.11.97. Epub 2011 Oct 3.

5.

Pharmacokinetics, pharmacodynamics and metabolism of the dimeric pyrrolobenzodiazepine SJG-136 in rats.

Reid JM, Buhrow SA, Kuffel MJ, Jia L, Spanswick VJ, Hartley JA, Thurston DE, Tomaszewski JE, Ames MM.

Cancer Chemother Pharmacol. 2011 Sep;68(3):777-86. doi: 10.1007/s00280-010-1517-4. Epub 2010 Dec 28.

PMID:
21188379
6.

Synergistic interactions between aminoflavone, paclitaxel and camptothecin in human breast cancer cells.

Reinicke KE, Kuffel MJ, Goetz MP, Ames MM.

Cancer Chemother Pharmacol. 2010 Aug;66(3):575-83. doi: 10.1007/s00280-009-1198-z. Epub 2009 Dec 11.

7.

Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen.

Schroth W, Goetz MP, Hamann U, Fasching PA, Schmidt M, Winter S, Fritz P, Simon W, Suman VJ, Ames MM, Safgren SL, Kuffel MJ, Ulmer HU, Boländer J, Strick R, Beckmann MW, Koelbl H, Weinshilboum RM, Ingle JN, Eichelbaum M, Schwab M, Brauch H.

JAMA. 2009 Oct 7;302(13):1429-36. doi: 10.1001/jama.2009.1420.

8.

Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide.

Myers RM, Greiner SM, Harvey ME, Griesmann G, Kuffel MJ, Buhrow SA, Reid JM, Federspiel M, Ames MM, Dingli D, Schweikart K, Welch A, Dispenzieri A, Peng KW, Russell SJ.

Clin Pharmacol Ther. 2007 Dec;82(6):700-10. Epub 2007 Oct 31.

9.

Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: a North Central Cancer Treatment Group trial.

Galanis E, Buckner JC, Maurer MJ, Reid JM, Kuffel MJ, Ames MM, Scheithauer BW, Hammack JE, Pipoly G, Kuross SA.

Invest New Drugs. 2005 Oct;23(5):495-503.

PMID:
16133802
10.

Rat and human liver cytochrome P-450 isoform metabolism of ecteinascidin 743 does not predict gender-dependent toxicity in humans.

Reid JM, Kuffel MJ, Ruben SL, Morales JJ, Rinehart KL, Squillace DP, Ames MM.

Clin Cancer Res. 2002 Sep;8(9):2952-62.

11.

Activation of the antitumor agent aminoflavone (NSC 686288) is mediated by induction of tumor cell cytochrome P450 1A1/1A2.

Kuffel MJ, Schroeder JC, Pobst LJ, Naylor S, Reid JM, Kaufmann SH, Ames MM.

Mol Pharmacol. 2002 Jul;62(1):143-53.

PMID:
12065765
12.

Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1.

Reid JM, Kuffel MJ, Miller JK, Rios R, Ames MM.

Clin Cancer Res. 1999 Aug;5(8):2192-7.

13.

Indolocarbazole poisons of human topoisomerase I: regioisomeric analogues of ED-110.

Zembower DE, Zhang H, Lineswala JP, Kuffel MJ, Aytes SA, Ames MM.

Bioorg Med Chem Lett. 1999 Jan 18;9(2):145-50.

PMID:
10021917
14.

Phase I and pharmacological trial of fazarabine (Ara-AC) with granulocyte colony-stimulating factor.

Goldberg RM, Reid JM, Ames MM, Sloan JA, Rubin J, Erlichman C, Kuffel MJ, Fitch TR.

Clin Cancer Res. 1997 Dec;3(12 Pt 1):2363-70.

15.
16.

Murine pharmacokinetics and metabolism of penclomedine [3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine, NSC 338720].

Reid JM, Mathiesen DA, Benson LM, Kuffel MJ, Ames MM.

Cancer Res. 1992 May 15;52(10):2830-4.

17.
18.

Preclinical pharmacology of the anthrapyrazole analog oxantrazole (NSC-349174, piroxantrone).

Frank SK, Mathiesen DA, Szurszewski M, Kuffel MJ, Ames MM.

Cancer Chemother Pharmacol. 1989;23(4):213-8.

PMID:
2924379
19.

Erythema nodosum; treatment with cortisone by mouth.

ALBRIGHT RW, KUFFEL MJ.

Calif Med. 1951 Nov;75(5):368-9. No abstract available.

20.

The value of antibiotics in diabetic surgery.

KUFFEL MJ, IRVIN LN, et al.

N Engl J Med. 1948 Jul 22;239(4):107-10. No abstract available.

PMID:
18870243
21.

Hyperinsulinism with hypoglycemia relieved by removal of pancreatic tumor.

KUFFEL MJ, FOSTER DP, LOWRIE WL.

Am J Dig Dis. 1947 Sep;14(9):279-81. No abstract available.

PMID:
20266684

Supplemental Content

Loading ...
Support Center